Western Sky Community Care Supports Pediatric Care in Ruidoso June 13, 2022 7:00 am|Health Plan Contributes $100,000 to BCA Pediatrics to Improve Access in Underserved Areas
Orvana Exhibits at 2022 PDAC Toronto, Canada June 13, 2022 7:00 am| TORONTO, June 13, 2022 /PRNewswire/ – Orvana Minerals Corp. (TSX: ORV) (the “Company” or “Orvana”) is pleased to…
Arturo Del Rio Named Vice President Human Resources, Chief People Officer of American Outdoor Brands June 13, 2022 7:00 am|COLUMBIA, Miss., June 13, 2022 /PRNewswire/ — American Outdoor Brands, Inc. (NASDAQ Global Select: AOUT), an industry leading…
Novavax COVID-19 Vaccine Nuvaxovid™ Provisionally Registered in Australia as a Booster in Individuals Aged 18 and Over June 13, 2022 7:00 am|
Curocell announced impressive CR rate in Phase 1 study with anbal-cel, the next generation CD19 CAR-T integrated OVIS™ platform June 13, 2022 7:00 am|– 82% ORR (9 of 11 patients) and 82% (9 of 11 patients) CR rate documented after anbal-cel…
LIVEONE AND 131 LIVE ANNOUNCE GLOBAL PAY-PER-VIEW PERFORMANCE BTBT: PERFORMANCE FANCON FOR K-POP RAPPER B.I June 13, 2022 7:00 am|Total Social Reach Over 5.8 Million Followers Worldwide
Drilling Commences at the Bonnie Claire Lithium Project, Nevada June 13, 2022 7:00 am|VANCOUVER, BC, June 13, 2022 /PRNewswire/ – Nevada Lithium Resources Inc. (CSE: NVLH) (OTCQB: NVLHF) (FSE: 87K) (“Nevada Lithium”…
Nanoscope Therapeutics to Provide Update on Optogenetic Approaches for Vision Restoration at BIO International June 13, 2022 7:00 am|DALLAS, June 13, 2022 /PRNewswire/ — Nanoscope Therapeutics, Inc., a clinical-stage biotechnology company developing gene therapies to treat…
POSITIVE DATA FOR PAXALISIB IN TWO CHILDHOOD BRAIN CANCERS PRESENTED AT 20TH ISPNO ANNUAL MEETING June 13, 2022 7:00 am|SYDNEY, June 13, 2022 /PRNewswire/ — Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company,…
NeoImmuneTech to Present at Upcoming BIO International Convention June 13, 2022 7:00 am| ROCKVILLE, Md., June 13, 2022 /PRNewswire/ — NeoImmuneTech, Inc. (NIT or “NeoImmuneTech”), a clinical-stage T cell-focused biopharmaceutical company, today…